
First molecular glue for NOS1AP tested in Alzheimer’s neurons
A preprint reports NOSTRA, the first molecular glue to stabilise the NOS1AP-SCRIB complex, tested in Alzheimer’s patient neurons.
MINIMUM bio News
Weekly news, deals and research on molecular glues, induced proximity and protein degradation, curated by the MINIMUM bio team.

A preprint reports NOSTRA, the first molecular glue to stabilise the NOS1AP-SCRIB complex, tested in Alzheimer’s patient neurons.

A Science paper describes FIND, a nanoswitch screen that selects molecules which induce or strengthen protein-protein interactions.

A preprint reports LZ6, a molecular glue stabilising the CHI3L1-Gal3BP complex that extended survival in a glioblastoma model.

Revolution Medicines’ Rasonque earned $198 million in its first five weeks, a strong debut for a non-degrading molecular glue drug.

Daraxonrasib (Rasonque) combination data at ESMO 2026, a second Phase 2 for Monte Rosa’s VAV1 glue degrader, and new AI tools for molecular glue research.
We partner with investors, pharma and biotech teams on first-in-class molecular glue targets.